Filing Details
- Accession Number:
- 0001209191-14-005335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-28 17:30:20
- Reporting Period:
- 2014-01-24
- Filing Date:
- 2014-01-28
- Accepted Time:
- 2014-01-28 17:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc., 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-24 | 27,324 | $2.01 | 901,503 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-24 | 30,000 | $2.01 | 931,503 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-24 | 116,253 | $9.01 | 815,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options | Disposition | 2014-01-24 | 27,324 | $0.00 | 27,324 | $2.01 |
| Common Stock | Options | Disposition | 2014-01-24 | 30,000 | $0.00 | 30,000 | $2.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-07-24 | 2018-07-24 | No | 4 | M | Direct |
| 0 | 2008-07-24 | 2018-07-24 | No | 4 | M | Direct |
Footnotes
- The sale of the shares of common stock was made pursuant to a 10b5-1 plan.
- On January 24, 2014, the Reporting Person sold an aggregate of 116,253 shares of the Issuer's Common Stock at a weighted average price of $9.01. The highest sale price for the Common Stock was $9.08 per share and the lowest sale price was $9.00 per share.
Billionaire Hedge Funds
